Skip to Content

The Alaska Department of Revenue has purchased 1,775 shares of Inari Medical, Inc. (NASDAQ:NARI)

The Alaska Department of Revenue has purchased 1,775 shares of Inari Medical, Inc. (NASDAQ:NARI)

The State of Alaska Department of Revenue increased its stake in Inari Medical, Inc. (NASDAQ: NARI) by 36.3% during the third quarter, as stated in the most recent report that it filed with the Securities and Exchange Commission (SEC). As a result, the institutional investor has a total of 6,660 shares of stock in the company they own after purchasing an additional 1,775 shares over the relevant period. This brings the total number of shares they own to 6,660. In addition, the most recent report submitted to the SEC indicates that the total value of the interest that the State of Alaska Department of Revenue had in Inari Medical was 483,000 dollars.

As a result of recent occurrences, a sizable number of additional institutional investors and hedge funds have shifted their positions about the stock. The Texas Permanent School Fund invested $1,671,100 in the common shares of Inari Medical during the second quarter of the fiscal year. In addition, the State of New Jersey Common Pension Fund D increased its holdings in Inari Medical by purchasing additional company shares during the second quarter and making a new investment of $2,652,000. During the second quarter, Renaissance Technologies LLC successfully increased the percentage of ownership it holds in Inari Medical by 105.6%. After acquiring an additional 99,800 shares during the preceding quarter, Renaissance Technologies LLC now possesses 194,299 shares of the company’s stock, currently valued at $13,211,000. Strs Ohio successfully increased the percentage of ownership it held in Inari Medical by 23.3% over the second quarter. In the most recent fiscal quarter, Strs Ohio acquired 1,000 shares of the company’s stock. This brings the total number of shares directly owned by the company to 5,300, with a value of $360,000 for the investment. During the second quarter, Brown Advisory Inc. achieved a 54.9% increase in the percentage of ownership it holds in Inari Medical. Following the purchase of 380,961 additional shares during the most recent quarter, Brown Advisory Inc. now owns 1,075,189 shares. The current market value of these shares is $73,197,00. At this time, institutions hold ownership of 85.19% of the outstanding stock shares.

On Tuesday, November 15, additional significant events took place in the world of business, one of which was the sale of 55,000 shares of the company’s stock by William Hoffman, the company’s CEO. A total of $4,491,850.00 was generated from the sale of the shares, which works out to an average price of $81.67 per share. According to the information disclosed in a filing with the SEC, which is available on its website of the SEC, the chief executive officer now owns 237,481 shares of the company’s stock, which have an approximate value of $19,395,073.27 as a result of the transaction. Again, this is to the information that was disclosed in the transaction. Additionally, on Tuesday, October 18, Director Donald B. Milder sold 7,000 shares of the company’s stock, as reported in other news articles concerning business and commerce. A total of $560,490.00 was made from the sale of the shares, which works out to an average price of $80.07 per share. Following the completion of the transaction, the director’s stock holdings in the company have increased to a total of 3,192,614 shares, which have a combined value of approximately $255,632,602,98. You might find a filing that explains the transaction in greater detail on the Securities and Exchange Commission (SEC) website.

Additionally, on November 15, William Hoffman, Chief Executive Officer of the company, sold 55,000 of the company’s shares of stock. The cost of each share was an average of $81.67 when purchased during the sale, which resulted in a total value of the transaction equal to $4,491,850.00. Because of the acquisition, the CEO now owns 237,481 shares of the company’s stock, estimated to be worth approximately $19,395,073.27. The disclosure about the purchase can be found in this particular location. According to the most recent financial filings, company insiders sold 261,500 shares of company stock during the past ninety days, bringing the total value of those sales to $19,453,713. At the moment, insiders own ninety percent of the company’s equity.

NASDAQ: NARI was first available for trading on Friday with an opening price of $65.87. Inari Medical, Inc.’s one-year low and one-year high is $50.50 per share. The price of the stock’s simple moving average over the past 50 days is $70.19, and the same metric over the past 200 days comes in at $72.71. Both the price-to-earnings ratio and the beta value for the company co

Tags

Leave a comment

Your email address will not be published. Required fields are marked *